chrisvoncsefalvay/vaers-outcomes huggingface dataset:
super numb; exhausted; This is a spontaneous report from a non-contactable consumer (patient's friend). A female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 12Apr2021 (Lot Number: ER8730) as single dose, for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 on 22Mar2021 (Lot number: EN6207) for COVID-19 Immunization and did not presented any symptoms. On 12Apr2021 , the patient mentioned that her arm in which she received the vaccine (left arm) got super numb for 6 or 7 hours after receiving the vaccine, as if she did not even could feel the arm normally that she was exhausted as if it was a run over sensation. The outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.
she got both doses then she found out she was pregnancy; she got both doses then she found out she was pregnancy; she got both doses then she found out she was pregnancy; she felt like she had the flu after both doses; This is a spontaneous report from a contactable Nurse, the patient. A contactable 36-year-old female pregnant patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EL3248), via an unspecified route of administration on 09Jan2021 as single dose for covid-19 immunization. The patient was previously administered first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: 201229-049), via an unspecified route of administration on 19Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, she found out she was pregnant and felt like she had the flu after both doses. The First day of menstrual period was reported as 27Nov2020. The patient Gestational period at time of initial exposure included She thinks the first dose would have been 3 weeks and second dose would have been 6 weeks. The patient has not taken any other drugs (e.g illicit drugs) during pregnancy. The patient did not smoke or drank alcohol during pregnancy. The patient reported that it is her her fourth pregnancy, she has 3 living kids. The outcome of the event, flu like symptoms was recovered, while other events was unknown.
REDUCED EYE VISION/WENT FROM 20/25 TO 20/40 IN BOTH EYES; This spontaneous report received from a patient concerned a 73 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: shotgun vision (She had Retinada pigmentosa, a hereditary problem, it's called shotgun vision. She was born with it. And according to her eye doctor this condition had been stable since 2015.), cholesterol, and high blood pressure. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for covid-19 prophylaxis. Age at time of vaccination 73 years old. No concomitant medications were reported. On 12-APR-2021, the patient experienced reduced eye vision/went from 20/25 to 20/40 in both eyes. Laboratory data included: Eye exam went from 20/25 to 20/40 in both eyes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from reduced eye vision/went from 20/25 to 20/40 in both eyes. This report was non-serious.; Sender's Comments: V0: V0:  Medical assessment comment not required as per standard procedure as the case is assessed as non serious.
The day right after my flu shot was given in top of left shoulder-pointing down. I had sharp pain in the shoulder. I could not raise the left arm to change my clothes by myself nor could I sleep except sitting up.
Nausea Dizzy Sore arm Headache Fatigue Fever  Chills Joint pain Muscle aches
Incorrect Pfizer vaccine given to patient. Patient was given 0.2mL dose out of the 12+ Pfizer Vaccine (Comirnaty). Patient is 7 years old and dose not qualify for this vaccine.  No reactions at this time. No treatment needed at this time. Doctor aware and has communicated to pt.'s parent the vaccine error and what to watch for.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.  On 02-Mar-2021 at 9:16 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 02-Mar-2021 at 9:16 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 65.85 for dose administered on 02-March-2021. No concomitant medications were reported. Batch number 014M20A underwent temperature excursion on 02-Mar-2021 with temperature 33 degrees Fahrenheit from 09:00 Am to 11:00 AM. This vial was moved to fridge on 24-Feb-2021. beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 02-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. No treatment medications were reported.
first dose of Shingrix on February 2019 / 2nd dose has not been received yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in February 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. Since the HCP (Health Care Professional) was driving and could not provide details. No patient identifiers, expiration date or lot number was provided. The reporter consented to follow up
Patient received vaccination at 1:22pm in a patient room. Taken to lobby to wait for monitoring. At 1:24 Nurse saw patient profusely sweating, staff brought patient to room. He stated he felt dizzy and weak, patient had assisted fall. Patient was pale and still diaphoretic and complaining of numbness and tingling in extremities and face. Respirations were 26 during that time. Patient laid supine, nursing staff put 4 L of O2 On via nasal cannula. O2 was 99% and maintained. Vitals 96/57, HR/58, RR 24, 99% alert and oriented x4. Patient stated he felt anxious and didn't have anything sine night before. After cold compress, respirations decreased and patient regained color. Patient later was able to dc home
45 min post injection pt had facial and eye swelling, itching and congestion. Given 25mg BENADRYL with relief  in 1 hr, complete  recovery by 3 hrs.
The night of the vaccination (3/8), my body felt very hot (not fever) like it was going to catch on fire.  I took Tylenol to be safe and went to bed taking it as a sign that the vaccine was working.  I thought I was mostly over the next day, but four days later on 3/12, I started bleeding only two weeks after my last period, and the it was quite different than usual - very fresh blood and lots of it.  This continued for 15 days at time with very heavy flow - I bleed non-stop, and I worried that I was going to bleed to death.  The worst adverse effect happened 10 days after the vaccination on 3/18.  Out of blue without anything unusual, I started feeling very dizzy, nausea, and vomiting.  After much vomiting, nausea stopped, but the dizziness just got so bad, I couldn't move or even keep my eyes open (things were spinning even with my eyes closed).  I couldn't even stand up by myself.  This most horrible severe vertigo lasted two and got gradually better.  It took about 5 days before I felt safe enough to be alone by myself.  During this time, I had a excruciating headache on my left side.  It was so bad, I quickly took some painkillers which knock me out for a day.  The important thing is that I don't ever get headaches; this is the first one I had aside from one I had when going through IVF more than a decade ago.
facilitations in the calves, and legs. feeling of wet sensation on left toes. sensation of hot feet
6 kids in her neighborhood have died after getting the Pfizer BioNtech Covid vaccine; This is a spontaneous report from a Pfizer Sponsored Program. A non-contactable consumer reporting same event under the same suspect product for 6 patients. This is one of 6 reports.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and the patient's concomitant medications were not reported.  The patient died on an unspecified date.  It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101253281 same reporter,same vaccine, same adverse event, different patient; Reported Cause(s) of Death: unknown cause of death
Patient mistakenly given Tdap instead of dTap for per age. No signs or symptoms of event
Had 1 hive on right cheek and left arm pain. Began Benadryl at 5:00 PM and continued for 24 hours.  Hive resided and no further hives developed.  Left arm pain was not as severe as with dose #2.  Resolved within 3 days.
Started as rash on vaccine site, then rash turned into blisters and opened. Had to go to urgent care to see doctor.
This case was reported by a physician via call center representative and described the occurrence of allergic reaction in a patient who received MENVEO for prophylaxis. Co-suspect products included BOOSTRIX for prophylaxis. On an unknown date, the patient received MENVEO at an unknown dose and BOOSTRIX at an unknown dose. On an unknown date, less than a day after receiving MENVEO and BOOSTRIX, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to MENVEO and BOOSTRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced allergic reaction after receiving both MENVEO and BOOSTRIX on the same day. The reporter was trying to obtain a sample of both to test the patient to.
Covid test result=Positive; Covid test result=Positive; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 16-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), in left arm and as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Crohns Disease" (unspecified if ongoing); "Migraines" (unspecified if ongoing); "Known allergies: Pineapple" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Augmentin, reaction(s): "Drug allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 18Oct2022, outcome "unknown" and all described as "Covid test result=Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Oct2022) Positive.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300272460 same patient, different dose/event;
Excessive, frequent urination for a 24 hour period following the second vaccination. Lost 5 lbs in 24 hours. This is in addition to the more normal reactions mentioned on web sites
On 09/10/2000 the patient's mother reported that the patient developed red dots generalized over his body. Within 24 hours she reported that they looked "blistery like chickenpox". Over the next 2 days he continued to break out and follow a chickenpox pattern but by day 4 they were not scabbing and drying like pox. The patient was seen by the physician. It was reported that the physician felt it was "dermatitis with impetiginous changes rather than pox". The physician determined that this was not a breakthrough case. On 09/18/2001 the patient recovered. No further information is available.
03/14, face flushed. 03/15, felt as if I was hit by the flu: chilled, aching, sore throat, feeling exhausted. 03/16 no sore throat but "dizzy," off-balance all day in addition to other symptoms. 03/17, not feeling chilled but  still feeling slightly "dizzy"  (off-balance) all day with mild aching and still feeling  tired. 03/18,  virtually all  symptoms disappeared.
Eyes lids are swollen; Eyes are itching; Back pain; Fatigue; Headache; Muscle ache; Sore arm at the injection site; This spontaneous case was reported by a patient and describes the occurrence of SWELLING OF EYELID (Eyes lids are swollen), EYE PRURITUS (Eyes are itching), BACK PAIN (Back pain), FATIGUE (Fatigue) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 Vaccine (Patient had 3 doses of Pfizer previously.). Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 Vaccine.    On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING OF EYELID (Eyes lids are swollen), EYE PRURITUS (Eyes are itching), BACK PAIN (Back pain), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle ache) and VACCINATION SITE PAIN (Sore arm at the injection site). At the time of the report, SWELLING OF EYELID (Eyes lids are swollen), EYE PRURITUS (Eyes are itching), BACK PAIN (Back pain), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle ache) and VACCINATION SITE PAIN (Sore arm at the injection site) outcome was unknown.            Concomitant medication details were not reported by the reporter. Reporter wanted to know if patient could take Benadryl or was there anything else Treatment details was not reported by the reporter.   Reporter did not allow further contact
Sypmtoms: SOB, chest pain, palor, clamy skin, vomiting, difficulty breathing. Time course: approximately 45 minutes. Tx: Oxygen at 6L/min, elevated feet, B/P check, pulse, resp. talon; EMS responded to TC for emergency care due to chest pain.
Received Moderna COVID 19 vaccine second dose on April 16th 2021 and days later began having chest pressure and shortness of breath. Was seen in doctor office and sent to ER. Was diagnosed with several blood clots in the lungs
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 23Sep2023 as dose 1, single (Batch/Lot number: unknown) at the age of 63 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Covid Rebound - 4 days after using Paxlovid and testing negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient received Paxlovid for treatment.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
I had my vaccination on 10/20/2022. On 03/29/2023 I started to have a sore throat body aches and fever and I tested COVID-19 Positive. I contacted my physician on 03/30/2023 and they prescribed Paxlovid. I am presently feeling better but I have not tested again. on 04/05/2023.
Muscle pain; injection site pain; headache; Very tired; Possible fever; This is a spontaneous report from a contactable consumer (patient). A 23-years-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 13Feb2021 11:30 (at the age of 23-year-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 13Feb2021 12:15 the patient experienced muscle pain, injection site pain, headache, very tired, possible fever. No therapeutic measure was taken. The patient underwent lab tests and procedures which included body temperature: unknown results. The outcome of events was unknown.   Information about lot/batch number has been requested.  Follow-up (11MAY2021): Follow-up attempts completed. No further information expected.
Janssen vaccine that expired 12/11/21 given on 12/13/21 in error. No adverse effects noted.  Contacted Manufacturer regarding the incident. Manufacturer supports stability up to 6 weeks post expiration and does not recommend a repeat dose.
Fever fatigue, very bad cough, chills, headache, earache, muscle aches.  Slept for two days.  Arm very red, swollen and painful with mild blistering
Initial information has been received from a physician refers to a male patient of unknown age with none pertinent medical history of drug reactions/allergies. The patient received 2 doses (on an unspecified date) of M-M-R II (lot number not provided) as a child. On 22-APR-2013, the physician gave a third dose of M-M-R II (lot and expiration date were not reported). On 18-JUN-2013, the patient came back to the office and had blood drawn to test for titers. The result were negative. On the same date, the patient was administered a 4th dose of M-M-R II (lot number and expiration date were not reported). There were not concomitant medications. The patient never seroconverted. The outcome was unknown. The action taken was not reported. Additional information has been requested.
p/vax pt had fever 102+ & rash, arthralgias;resolved;
No adverse event; Patient received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 48-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 006M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Sep-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 20-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine).    No concomitant medications were reported. It was unknown if patient had allergies to medication, foods and other products.  It was unknow if patient had ever been diagnosed with and or tested positive with COVID-19. Acute illness at the time of vaccination and up to one month before was unknown. Expired Moderna vaccine had been given to 21 patients. The reporter explained that the vial was taken out of the freezer recently. The vial size was 5.5 ml. The vial was initially stored in the refrigerator on 20-Sep-2022. The vial did not undergone any temperature excursion. No treatment medications were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2022: Live follow up received contains reporter address updated.
somnolence & cellulitis are reported in a pt who recvd flu vax; pt was treated w/Medrol dose pack; this is 1 of 3 pts reported at this site;
Fever (102.6 while on ibuprofen) about 18 hours, Fatigue about 36 hours, Severe joint pain head to toe about 24 hours.
2/17-2/18 congestion, chills, fever 101.8F, fatigue, body aches 2/18 nausea, sore throat, headache (intermittent) treated with Advil